1. Bacterial contamination of Eco-Med's health products

   News item 11 September 2021 Pages: 1 - 1

2. FDA requires updated safety warnings for Janus kinase inhibitors

   News item 11 September 2021 Pages: 2 - 2

3. Further losartan lots recalled in Canada due to azido impurity

   News item 11 September 2021 Pages: 3 - 3

4. Minocycline-related agranulocytosis

   News item 11 September 2021 Pages: 4 - 4

5. Voluntary recall of Teligent Pharma's lidocaine topical solution

   News item 11 September 2021 Pages: 5 - 5

6. Warnings of risks associated with ivermectin use for COVID-19

   News item 11 September 2021 Pages: 6 - 6

7. Anti-infective combination therapy increases risk of acute kidney injury

   Clinical study 11 September 2021 Pages: 7 - 7

8. Atovaquone/proguanil plus amodiaquine: CNS safety signal

   Clinical study 11 September 2021 Pages: 8 - 8

9. Ibrutinib increases risk of AF, HF and haemorrhage

   Clinical study 11 September 2021 Pages: 9 - 9

10. Inhaled corticosteroids increase risk of P. aeruginosa infection

    Clinical study 11 September 2021 Pages: 10 - 10

11. mRNA-based vs viral vector-based COVID-19 vaccines

    Clinical study 11 September 2021 Pages: 11 - 11

12. Regular use of proton pump inhibitors increases risk of IBD

    Clinical study 11 September 2021 Pages: 12 - 12

13. Other adverse reaction research

    News item 11 September 2021 Pages: 13 - 13

14. Abemaciclib/fulvestrant

    Case report 11 September 2021 Pages: 14 - 14

15. Acenocoumarol/amoxicillin/clavulanic-acid

    Case report 11 September 2021 Pages: 15 - 15

16. Acetazolamide

    Case report 11 September 2021 Pages: 16 - 16

17. Aciclovir/midazolam

    Case report 11 September 2021 Pages: 17 - 17

18. Ad26.cov2-s

    Case report 11 September 2021 Pages: 18 - 18

19. Adalimumab

    Case report 11 September 2021 Pages: 19 - 19

20. Adalimumab/certolizumab pegol/secukinumab

    Case report 11 September 2021 Pages: 20 - 20

21. Adalimumab/etanercept

    Case report 11 September 2021 Pages: 21 - 21

22. Adalimumab/prednisone

    Case report 11 September 2021 Pages: 22 - 22

23. Aflibercept

    Case report 11 September 2021 Pages: 23 - 23

24. Ajmaline

    Case report 11 September 2021 Pages: 24 - 24

25. Albendazole/steroids

    Case report 11 September 2021 Pages: 25 - 25

26. Alemtuzumab

    Case report 11 September 2021 Pages: 26 - 26

27. Allopurinol

    Case report 11 September 2021 Pages: 27 - 27

28. Allopurinol/cemiplimab

    Case report 11 September 2021 Pages: 28 - 28

29. Amantadine/levodopa/carbidopa/pramipexole

    Case report 11 September 2021 Pages: 29 - 29

30. Amiodarone

    Case report 11 September 2021 Pages: 30 - 30

31. Amiodarone

    Case report 11 September 2021 Pages: 31 - 31

32. Amiodarone/carvedilol/dabigatran-etexilate interaction

    Case report 11 September 2021 Pages: 32 - 32

33. Amiodarone/digoxin/propafenone

    Case report 11 September 2021 Pages: 33 - 33

34. Amiodarone/flecainide

    Case report 11 September 2021 Pages: 34 - 34

35. Amlodipine/labetalol/spironolactone

    Case report 11 September 2021 Pages: 35 - 35

36. Amoxicillin/clavulanic-acid/Amoxicillin

    Case report 11 September 2021 Pages: 36 - 36

37. Amoxicillin/clavulanic-acid/paracetamol/simvastatin

    Case report 11 September 2021 Pages: 37 - 37

38. Amphotericin-B-liposomal/cefoperazone/sulbactam

    Case report 11 September 2021 Pages: 38 - 38

39. Amphotericin-B/meglumine-antimonate/sodium-stibogluconate

    Case report 11 September 2021 Pages: 39 - 39

40. Ampicillin/sulbactam

    Case report 11 September 2021 Pages: 40 - 40

41. Anastrozole

    Case report 11 September 2021 Pages: 41 - 41

42. Antibacterials

    Case report 11 September 2021 Pages: 42 - 42

43. Antibacterials

    Case report 11 September 2021 Pages: 43 - 43

44. Antibacterials/ethambutol

    Case report 11 September 2021 Pages: 44 - 44

45. Antiepileptic-drugs

    Case report 11 September 2021 Pages: 45 - 45

46. Antifungals/immunosuppressants

    Case report 11 September 2021 Pages: 46 - 46

47. Antihyperglycaemics

    Case report 11 September 2021 Pages: 47 - 47

48. Antineoplastics

    Case report 11 September 2021 Pages: 48 - 48

49. Antineoplastics

    Case report 11 September 2021 Pages: 49 - 49

50. Antineoplastics

    Case report 11 September 2021 Pages: 50 - 50